The SARS-CoV-2 (2019-nCoV) Multiplex qRT-PCR Detection Kit is designed based on real time RT-PCR for the direct qualitative detection of 2019-nCoV RNA in respiratory specimens. The kit is for research use only, not for diagnoses.
Target
SARS-CoV-2
Specificity
SARS-CoV-2 virus genome.
Contents
Reaction Mix; Enzyme Mix; Internal Control RNA; No Template Control; Positive Control.
Testing
SARS-CoV-2
Testing Principle
Real-time RT-PCR
Applications
In vitro detection of SARS-CoV-2 (2019-nCoV) in respiratory specimens.
Storage
Store away from light at -20°C.
Introduction
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.